Skip to main content
Premium Trial:

Request an Annual Quote

Eli Mintz, Vincent Zurawski, Lior Maayan, Miguel Rios, Bruce Carp

Premium

Eli Mintz has stepped down from his position of president of Compugen Inc., the Jamesburg, NJ-based subsidiary of Israel’s Compugen, and will serve as the chairman of the subsidiary. In his new position, Mintz said he will “continue to participate in the further development of the company while, at the same time, having the time and opportunity to explore some other interests of mine as well as new ventures.”

Mintz co-founded Compugen in 1993 and has held a number of senior positions, including CEO of the parent company. He will continue to serve as a member of the parent company’s board of directors.

Mintz’s responsibilities will be absorbed by Vincent Zurawski, CEO of Compugen Inc., who has overall executive responsibilities for the subsidiary, and Lior Maayan, executive vice president of corporate development and planning, who will head up all corporate development activities.

 

Gaithersburg, Md.-based Viaken Systems has appointed Michael Provance to the newly created position of vice president of Discovery Solutions, a new effort that unites the company’s professional services, managed services, and solutions products efforts into a single delivery unit. Provance was previously executive director of the company’s Global Professional Services unit.

 

Miguel Rios has been elected chairman of the board of the National Center for Genome Resources. Rios replaces Bruce Carp, who served as chairman since NCGR’s founding seven years ago. Carp will remain on the board.

Rios, who has been on the NCGR board since its inception, was appointed interim president and CEO in July and will continue to serve into 2002.

Filed under

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.